Medical debt remains a defining feature of the U.S. consumer credit system.
Throughout the 2025 legislative cycle and into 2026, medical debt collection has continued to draw significant attention from policymakers at both the state and federal levels. States across the country have introduced or advanced legislation addressing how medical debt is billed, collected, and reported, reflecting sustained interest in regulating healthcare-related financial obligations within consumer protection, healthcare, and credit reporting frameworks.
At the federal level, recent actions under the Trump administration have reshaped the policy landscape. In late 2025 and early 2026, the administration reversed Biden-era initiatives that would have removed most medical debt from consumer credit reports. Through regulatory action and litigation positions taken by the Consumer Financial Protection Bureau, the administration has asserted that federal credit reporting law may preempt state laws restricting the reporting of medical debt. These developments have introduced legal uncertainty for existing and proposed state bans, even as states continue to pursue their own reforms.
Despite this federal shift, states remain active in regulating medical debt, particularly credit reporting practices. Many have enacted or proposed laws that prohibit reporting altogether or impose conditions before reporting may occur, such as extended billing and dispute periods or limits on the types of medical debt that may be reported.
Other prominent legislative trends include efforts to:
- Expand billing clarity, notice requirements, and pricing transparency;
- Extend timelines before medical accounts may be referred to collections; and
- Require payment plans and financial assistance screenings prior to collection activity.
In addition, several states are pursuing medical debt relief initiatives that use public funds or pilot programs to purchase and retire qualifying medical debt. While these programs vary by jurisdiction, they signal growing interest in reducing existing medical debt burdens rather than focusing solely on future collection practices.
Recently introduced D.C. B26-0438 reflects these national trends. The bill addresses both upstream drivers of medical debt – such as pricing standards, transparency, and financial assistance eligibility – and downstream practices related to collections and credit reporting, while incorporating explicit enforcement mechanisms. If enacted, it could significantly affect provider billing, assistance determinations, and collection operations.
Why It Matters for the Industry:
- Credit reporting restrictions and federal preemption uncertainty complicate compliance for furnishers and credit bureaus operating across state lines.
- Expanded financial assistance and transparency requirements may require operational changes for providers, billing vendors, and compliance teams.
- New limits on collection activity, including restrictions on lawsuits, liens, and garnishment, could alter revenue cycle strategies.
- Standardized income thresholds and good-faith estimate requirements reflect a continued shift toward more consumer-centric pricing expectations.
Together, evolving state legislation and federal retrenchment underscore a fragmented and dynamic medical debt policy environment with significant implications for healthcare providers, debt collectors, credit reporting agencies and the broader consumer credit ecosystem. FOCUS will continue to monitor developments on medical debt in the credit landscape in state legislatures across the country.
by Hollie Friot 1/19/26
